scispace - formally typeset
W

Wieland Meyer

Researcher at University of Sydney

Publications -  267
Citations -  15732

Wieland Meyer is an academic researcher from University of Sydney. The author has contributed to research in topics: Cryptococcus gattii & Cryptococcus neoformans. The author has an hindex of 66, co-authored 245 publications receiving 13757 citations. Previous affiliations of Wieland Meyer include Duke University & Humboldt University of Berlin.

Papers
More filters
Journal ArticleDOI

Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis

TL;DR: A qualitative environmental survey encompassing 25 urban, semirural and rural sites in the greater Sydney region revealed an abundance of Pseudallescheria/Scedosporium, particularly in locations associated with high human activity, highlighting the importance of environmental studies to assess the clinical risk of infection.
Journal ArticleDOI

Clonality and α-a Recombination in the Australian Cryptococcus gattii VGII Population - An Emerging Outbreak in Australia

TL;DR: The detection of sexual recombination in MATα-MAT a population in Australia is in accordance with the natural life cycle of C. gattii involving opposite mating types and presents an alternative to the same-sex mating strategy suggested elsewhere.
Journal ArticleDOI

The use of DNA-fingerprint analysis in the classification of some species of the Trichoderma aggregate

TL;DR: The results show that RFLP analysis may be used to re-classify the Trichoderma aggregate, and contradict the claim that T. reesei is a subspecies of T. longibrachiatum.
Journal ArticleDOI

Clinical features and epidemiology of cryptococcosis in cats and dogs in California: 93 cases (1988–2010)

TL;DR: Strains of Cryptococcus spp appeared to have host specificity in dogs and cats and distribution of involved tissues was different between cats and dogs in California and between populations of the present study and those of the previously reported Australian study.
Journal ArticleDOI

Mucormycosis in Australia: contemporary epidemiology and outcomes

TL;DR: Underlying rheumatological/autoimmune disorders are a previously under-appreciated risk for infection and poor outcome, and the mortality of mucormycosis remains particularly high in the immuno-compromised host.